The aim of the study was to develop new synthetic anti-inflammatory and cytotoxic agents targeting NF-kappaB Nuclear factor-kappaB (NF-kappaB) has been reported to regulate various genes involved in cancer and inflammation. Accordingly, drugs inhibiting NF-kappaB may possess both anti-inflammatory and anticancer properties. So there is a need to discover novel compounds which should not only...